*ST吉藥(300108.SZ):本草匯醫藥所持1593.1萬股將被司法拍賣
格隆匯3月28日丨*ST吉藥(300108.SZ)公佈,公司近日通過股東本草匯醫藥提供的《執行裁定書》案號:(2023)吉0602執恢128號、《執行裁定書》案號:(2023)吉0602執恢129號及在淘寶網司法拍賣網絡平台查詢獲悉,白山市渾江區人民法院將於2023年4月27日10時至2023年4月28日10時止(延時除外)在白山市渾江區人民法院阿里巴巴司法拍賣網絡平台上對本草匯醫藥持有公司的1593.1006萬股無限售流通股(佔公司總股本的2.39%)進行公開網絡司法拍賣活動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.